Biotech2 years ago
REvalMed Completes IPTs for Six New Drugs
At its latest meeting, held July 28th, REvalMed group has agreed to start work on the Therapeutic Positioning Reports (TPRs) for vutrisiran, voclosporin, tirzepatide, fosdenopterin, relatlimab...